Discontinued — last reported Q2 '20
West Pharmaceutical Services Lease Liability Payments - Due Year Two decreased by 26.7% to $1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.10M to $1.10M. Over 3 years (FY 2020 to FY 2023), Lease Liability Payments - Due Year Two shows an upward trend with a 14.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Provides insight into the company's fixed cost commitments and long-term operational leverage.
The projected cash payments for operating and finance leases scheduled for the second year following the balance sheet d...
Standard disclosure for lease maturity profiles.
lease_liability_payments_due_year_2| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.40M | $9.30M | $10.70M | $11.10M | $11.60M | $14.90M | $18.10M | $16.20M | $16.70M | $17.10M | $15.70M | $16.50M | $900.00K | $900.00K | $1.10M | $1.30M | $1.50M | $1.10M |
| QoQ Change | — | -1.1% | +15.1% | +3.7% | +4.5% | +28.4% | +21.5% | -10.5% | +3.1% | +2.4% | -8.2% | +5.1% | -94.5% | +0.0% | +22.2% | +18.2% | +15.4% | -26.7% |
| YoY Change | — | — | — | — | +23.4% | +60.2% | +69.2% | +45.9% | +44.0% | +14.8% | -13.3% | +1.9% | -94.6% | -94.7% | -93.3% | +44.4% | +66.7% | +0.0% |